Published in J Immunol Methods on May 12, 1997
IgM Chlamydia Trachomatis Antibodies in Cases of Melasma. Med J Armed Forces India (2011) 0.80
Prevalence of Chlamydia trachomatis immunoglobulin G antibodies in infertile women attending an in vitro fertility center. Indian J Sex Transm Dis (2015) 0.75
Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria. J Clin Endocrinol Metab (1997) 2.30
Heterogeneity of human peripheral blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol (1983) 2.17
Rapid genotyping of the Chlamydia trachomatis major outer membrane protein by the polymerase chain reaction. FEMS Microbiol Lett (1991) 2.08
Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis. J Clin Microbiol (1997) 2.08
[Chlamydia trachomatis urogenital infections in women. Best diagnostic approaches]. Gynecol Obstet Fertil (2004) 2.04
STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood (1996) 1.99
Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med (1992) 1.88
Role of IgE receptors in effector function of human eosinophils. J Immunol (1984) 1.87
Modifications of the envelope of Chlamydia psittaci during its developmental cycle: freeze-fracture study of complementary replicas. J Bacteriol (1980) 1.70
Glycoprotein IIb-IIIa is expressed on avian multilineage hematopoietic progenitor cells. Blood (1999) 1.67
Fc receptors for IgE on human and rat eosinophils. J Immunol (1981) 1.63
Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proc Natl Acad Sci U S A (1997) 1.60
Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol Rev (1996) 1.50
Specific mucosal erosions in hypereosinophilic syndrome. Evidence for eosinophil protein deposition. Arch Dermatol (1996) 1.48
The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae. J Clin Pathol (1999) 1.46
[Study with electron microscopy of the development and morphology of Chlamydia psittaci in mouse macrophages]. Ann Inst Pasteur (Paris) (1970) 1.43
Ofuji papuloerythroderma. Report of a case with T cell skin lymphoma and discussion of the nature of this disease. J Am Acad Dermatol (1989) 1.42
[Retrospective analysis of 1331 samples of cerebrospinal fluid in newborn infants with suspected infection]. Arch Pediatr (1995) 1.38
Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. J Infect Dis (2000) 1.36
The synergism of accessory cells and of soluble alpha-factors derived from them in the activation of B cells to proliferation. Immunol Rev (1984) 1.34
Tolerance induced by thymic epithelial grafts in birds. Science (1987) 1.34
Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. Clin Exp Immunol (1984) 1.28
Expression of a human endogenous retrovirus, HERV-K, in the blood cells of leukemia patients. Leukemia (2002) 1.28
Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. J Gen Virol (1998) 1.27
Serotyping of Chlamydia psittaci by the micro-immunofluorescence test: isolates of ovine origin. Infect Immun (1982) 1.27
Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics. Leukemia (2005) 1.27
BEN, a surface glycoprotein of the immunoglobulin superfamily, is expressed in a variety of developing systems. Proc Natl Acad Sci U S A (1992) 1.26
Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection. Infect Immun (1994) 1.24
Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer (1994) 1.24
T-cell hybridomas which produce B lymphocyte replication factors only. Nature (1982) 1.20
Usefulness of omp1 restriction mapping for avian Chlamydia psittaci isolate differentiation. Res Microbiol (1995) 1.19
Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital. J Clin Microbiol (2001) 1.19
Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases. Ann Rheum Dis (2004) 1.19
Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry. J Immunol (1985) 1.18
Restriction pattern of the major outer-membrane protein gene provides evidence for a homogeneous invasive group among ruminant isolates of Chlamydia psittaci. J Gen Microbiol (1991) 1.18
Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation. J Allergy Clin Immunol (1991) 1.15
Requirement for macrophages or for macrophage- or T cell-derived factors in the mitogenic stimulation of murine B lymphocytes by lipopolysaccharides. Eur J Immunol (1983) 1.14
Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome. J Clin Immunol (2008) 1.13
Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor. J Exp Med (1990) 1.12
Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J Hosp Infect (2002) 1.11
Role of specific IgE antibodies in peroxidase (EPO) release from human eosinophils. J Immunol (1986) 1.11
HTLV-I and malignant hypereosinophilic syndrome. Lancet (1988) 1.10
Monoclonal antibodies in serovar determination of 53 Chlamydia trachomatis isolates from Amiens, France. Res Microbiol (1991) 1.08
Cytokine-mediated bone resorption in patients with the hyperimmunoglobulin E syndrome. Clin Immunol Immunopathol (1995) 1.07
Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients. J Allergy Clin Immunol (1984) 1.07
Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood (1993) 1.06
Specific receptors for the serum thymic factor (FTS) in lymphoblastoid cultured cell lines. Proc Natl Acad Sci U S A (1980) 1.06
Functional study of a monoclonal antibody to IgE Fc receptor (Fc epsilon R2) of eosinophils, platelets, and macrophages. J Exp Med (1986) 1.05
[Value of the head-up tilt test in the etiologic diagnosis of syncope]. Presse Med (1990) 1.01
Radical changes to chlamydial taxonomy are not necessary just yet. Int J Syst Evol Microbiol (2001) 0.99
Primary biliary cirrhosis. Subclinical inflammatory alveolitis in patients with normal chest roentgenograms. Chest (1986) 0.99
Morphological and cytochemical study of Chlamydia with EDTA regressive technique and Gautier staining in ultrathin frozen sections of infected cell cultures: a comparison with embedded material. Ann Microbiol (Paris) (1978) 0.98
Monitoring of microbial adhesion and biofilm growth using electrochemical impedancemetry. Appl Microbiol Biotechnol (2008) 0.98
Functional role of the alpha-chain of complement receptor type 3 in human eosinophil-dependent antibody-mediated cytotoxicity against schistosomes. J Immunol (1987) 0.98
The role of thymic epithelium in the establishment of transplantation tolerance. Immunol Rev (1993) 0.98
Prevalence of methicillin-resistant Staphylococcus aureus carriage at the time of admission in two acute geriatric wards. J Hosp Infect (2002) 0.97
Biochemical and functional characterization of an avian homolog of the integrin GPIIb-IIIa present on chicken thrombocytes. Exp Cell Res (1994) 0.97
The pharmacokinetics of ceftriaxone and cefotaxime in cirrhotic patients with ascites. Eur J Clin Pharmacol (1989) 0.96
IgE-binding molecules (Mac-2/epsilon BP) expressed by human eosinophils. Implication in IgE-dependent eosinophil cytotoxicity. Eur J Immunol (1993) 0.95
[Serotyping of "Chlamydia psittaci" by microimmunofluorescence test (author's transl)]. Ann Microbiol (Paris) (1981) 0.94
Human eosinophils express CR1 and CR3 complement receptors for cleavage fragments of C3. Cell Immunol (1986) 0.94
[Bone involvement in idiopathic calcium lithiasis]. Nephrologie (1995) 0.94
Increased interleukin-6 production during the acute phase of the syndrome of episodic angioedema and hypereosinophilia. Clin Exp Allergy (1998) 0.93
Fluorescent antibodies in the fluid of the conjunctival sac of trachoma patients. Nature (1966) 0.93
[Ultrastructure and cytochemistry of Chlamydia Psittaci]. Arch Gesamte Virusforsch (1971) 0.93
Variations in protein expression related to human eosinophil heterogeneity. J Immunol (1989) 0.93
Ultrastructural study of the development of the agent of ewe's abortion. J Ultrastruct Res (1976) 0.93
Synthesis of type 1 (IFN gamma) and type 2 (IL-4, IL-5, and IL-10) cytokines by human eosinophils. Ann N Y Acad Sci (1996) 0.93
Roxithromycin treatment of mouse chlamydial salpingitis and protective effect on fertility. Antimicrob Agents Chemother (1991) 0.93
Heterogeneity within the first constant segment of the major outer membrane protein gene in Chlamydia trachomatis serovar D/Da distinguishes 2 lineages. C R Acad Sci III (1995) 0.92
[Risk of deep infection in first-intention total hip replacement. Evaluation concerning a continuous series of 790 cases]. Presse Med (2001) 0.92
Chlamydial endocarditis: a report on ten cases. Eur Heart J (1992) 0.92
Regulation of B lymphocyte replication and maturation. J Cell Biochem (1982) 0.92
[Epidemiology of Chlamydia trachomatis using analysis of gene encoding of the major outer membrane protein]. Pathol Biol (Paris) (1992) 0.91
Avian VEGF-C: cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors. Development (1998) 0.91
Limits of the microimmunofluorescence test and advantages of immunoblotting in the diagnosis of chlamydiosis. Clin Diagn Lab Immunol (1996) 0.91
[Hypereosinophilic syndrome with pachyderma preceding lymphoma. Treatment with interferon alpha]. Ann Dermatol Venereol (1991) 0.91
T lymphocyte activation in systemic lupus erythematosus analysed by proliferative response to nucleoplasmic proteins on nitrocellulose immunoblots. Clin Exp Immunol (1989) 0.91
Community-acquired multiresistant bacteria: an emerging problem? J Hosp Infect (2001) 0.90
Epidemiological study of an Acinetobacter baumannii outbreak by using a combination of antibiotyping and ribotyping. J Clin Microbiol (1999) 0.90
Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation. Blood (1992) 0.89
Genotyping of Portuguese Chlamydia trachomatis urogenital isolates. Genitourin Med (1997) 0.89
[Phase contrast microcinematographic analysis of the intracellular development of Chlamydia psittaci]. Arch Gesamte Virusforsch (1971) 0.88
[Stenotrophomonas maltophilia and Pseudomonas aeruginosa water-associated microbiologic risk assessment in Amiens' University Hospital Centre]. Pathol Biol (Paris) (2009) 0.88
Pharmacological screening of plant decoctions commonly used in Cuban folk medicine. J Ethnopharmacol (1991) 0.88
Eotaxin expression and eosinophil infiltrate in the liver of patients with drug-induced liver disease. J Hepatol (2001) 0.88
Successive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital. J Clin Microbiol (2008) 0.87
Chlamydia trachomatis peritonitis: another cause of protein-rich lymphocytic ascites. J Clin Gastroenterol (1990) 0.86
[Epidemiologic significance of the immunofluorescence typing of Chlamydia psittaci]. Ann Inst Pasteur Microbiol (1988) 0.86
Activated Stat related transcription factors in acute leukemia. Leuk Lymphoma (1997) 0.86